SVB’s collapse is a reminder of how far IP finance still has to travel
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Marconi's Kasim Alfalahi takes the top spot for Avanci's stellar showing in our countdown of the patent market’s most innovative and influential dealmakers and decision takers
We compiled data from Westfleet Advisors’ annual litigation funding reports to find patent finance shot up by nearly 50% since 2020 – to the benefit of rights holders
Versatile biotechnologies are changing patterns of collaboration among healthcare innovators
10 February 2022
The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets
03 February 2022
The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have
03 February 2022
Tech sector brand assets gained significant value over the past year, according to the latest Brand Finance Global 500
31 January 2022
Spate of recent transactions show the value of gene-editing patents beyond Cas9
28 January 2022
Nader Mousavi, Mehdi Ansari, Jay Thornton and Jonathan Hofman of Sullivan & Cromwell explore the legal issues facing creators and buyers of NFTs, alongside the regulatory frameworks in which they are being used
19 January 2022
“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call
22 December 2021
The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced
20 December 2021
The president’s choice for director of the agency sees uptick in positive sentiment towards the administration’s policies in the survey findings for IAM’s Q4 Panel Report
09 December 2021
Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries
04 December 2021
Unlock unlimited access to all IAM content